financetom
Business
financetom
/
Business
/
Gilead Sciences Says Antitrust Waiting Period for CymaBay Therapeutics Deal Expires
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Gilead Sciences Says Antitrust Waiting Period for CymaBay Therapeutics Deal Expires
Mar 11, 2024 7:03 AM

09:43 AM EDT, 03/11/2024 (MT Newswires) -- Gilead Sciences ( GILD ) said Monday the waiting period under the Hart-Scott-Rodino antitrust law expired on Friday for its cash offer to acquire CymaBay Therapeutics.

CymaBay Therapeutics shareholders have until late March 21 to offer Gilead a majority of outstanding shares, Gilead said.

Price: 76.01, Change: +0.88, Percent Change: +1.18

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2025 - www.financetom.com All Rights Reserved